第2016-32期 Targeting Bcl-2 Family Proteins with Highly Potent and Selective Small Molecule Inhibitors: Discovery of New Anti-Cancer Medicine Venetoclax/VenclextaTM

报告题目：Targeting Bcl-2 Family Proteins with Highly Potent and Selective Small Molecule Inhibitors:  Discovery of New Anti-Cancer Medicine Venetoclax/VenclextaTM

报告人：陶志福（艾伯维制药集团癌症研究部首席科学家）

时间：6月21日下午4:00

地点：化学楼五楼学术报告厅